Literature DB >> 11982837

Diffusion of ketoprofen into the cerebrospinal fluid of young children.

Hannu Kokki1, Marko Karvinen, Antti Jekunen.   

Abstract

BACKGROUND: The objective was to examine whether or not ketoprofen enters the cerebrospinal fluid after a single oral dose of 1 mg.kg-1 syrup, and to find out what is the lowest plasma concentration that will achieve a measurable level in the cerebrospinal fluid.
METHODS: We measured ketoprofen concentrations both in plasma and cerebrospinal fluid of 10 young and healthy children (aged 9-86 months) after surgery with spinal anaesthesia. Samples of cerebrospinal fluid were collected 30 min after drug administration, at the same time as venous blood samples. A validated high-performance liquid chromatography method with a lower limit of 0.02 microg x ml(-1) was used to detect ketoprofen concentrations in cerebrospinal fluid and plasma.
RESULTS: Ketoprofen was detectable in the cerebrospinal fluid only in the child who had the highest plasma concentration, 7.4 microg x ml(-1), while at plasma concentrations 6.5 microg x ml(-1) or less, cerebrospinal fluid (CSF) concentrations remained unmeasurable. The detected CSF/plasma ratio was 0.008.
CONCLUSIONS: These results indicate that ketoprofen at a dose of 1 mg x kg(-1) is too low to produce measurable CSF levels within 30 min of oral administration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982837     DOI: 10.1046/j.1460-9592.2002.00808.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  7 in total

1.  Cerebrospinal fluid distribution of ketoprofen after intravenous administration in young children.

Authors:  Anne Mannila; Hannu Kokki; Marja Heikkinen; Merja Laisalmi; Marko Lehtonen; Hanna L Louhisto; Tomi Järvinen; Jouko Savolainen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  The Cerebrospinal Fluid Distribution of Postoperatively Administred Dexketoprofen and Etoricoxib and Their Effect on Pain and Inflammatory Markers in Patients Undergoing Hip Arthroplasty.

Authors:  Annika Piirainen; Merja Kokki; Heidi Hautajärvi; Marko Lehtonen; Hannu Miettinen; Kari Pulkki; Veli-Pekka Ranta; Hannu Kokki
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

Review 3.  Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

Review 4.  Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.

Authors:  Victoria C Ziesenitz; Tatjana Welzel; Madelé van Dyk; Patrick Saur; Matthias Gorenflo; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2022-09-02       Impact factor: 3.930

5.  Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.

Authors:  Shivani V Gandhi; William Rodriguez; Mansoor Khan; James E Polli
Journal:  AAPS PharmSciTech       Date:  2014-02-21       Impact factor: 3.246

6.  Antipyretic effect of ketoprofen.

Authors:  S Celebi; M Hacimustafaoglu; D Aygun; E S Arisoy; Y Karali; S Akgoz; A N Citak Kurt; M Seringec
Journal:  Indian J Pediatr       Date:  2009-01-05       Impact factor: 1.967

Review 7.  Nonsteroidal anti-inflammatory drugs for postoperative pain: a focus on children.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.